Effect of L-methionine on hot flashes in postmenopausal women: A randomized controlled trial

Menopause

Volumn 16, Issue 5, 2009, Pages 1004-1008

  Guttuso Jr , Thomas ^a   McDermott, Michael P ^b   Ng, Phillip ^b   Kieburtz, Karl ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Amino acid; Clinical trial; Homocysteine; Hot flashes; Menopause; Methionine

Indexed keywords

FOLIC ACID; MECOBALAMIN; METHIONINE; PLACEBO;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT FAILURE;

AMINES; ANALYSIS OF VARIANCE; CYCLOHEXANECARBOXYLIC ACIDS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GAMMA-AMINOBUTYRIC ACID; HOMOCYSTEINE; HOT FLASHES; HUMANS; INTESTINAL ABSORPTION; MEDICAL RECORDS; METHIONINE; MIDDLE AGED; POSTMENOPAUSE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 73349117799     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181a2fa76     Document Type: Article

References (26)

1. Butt DA, Lock M, Lewis JE, Ross S, Moineddin R. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial. Menopause 2008; 15:310-318. (Pubitemid 351354993)
2. Guttuso T Jr, Kurlan R, McDermott MP, Kieburtz K. Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003; 101:337-345. (Pubitemid 36170136)
3. Pandya KJ, Morrow GR, Roscoe JA, et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebocontrolled trial. Lancet 2005; 366:818-824.
4. Reddy SY, Warner H, Guttuso T Jr, et al. Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial. Obstet Gynecol 2006; 108:41-48. (Pubitemid 44336843)
5. Stefani A, Spadoni F, Giacomini P, Lavaroni F, Bernardi G. The effects of gabapentin on different ligand- and voltage-gated currents in isolated cortical neurons. Epilepsy Res 2001; 43:239-248. (Pubitemid 32204449)
6. Sutton KG, Martin DJ, Pinnock RD, Lee K, Scott RH. Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones. Br J Pharmacol 2002; 135:257-265. (Pubitemid 34102120)
7. 3H] Gabapentin may label a system-L-like neutral amino acid carrier in brain. Eur J Pharmacol 1993; 247:341-345.
8. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324:1149-1155.
9. Ditscheid B, Funfstuck R, Busch M, Schubert R, Gerth J, Jahreis G. Effect of L-methionine supplementation on plasma homocysteine and other free amino acids: a placebo-controlled double-blind cross-over study. Eur J Clin Nutr 2005; 59:768-775. (Pubitemid 40894941)
10. van der Griend R, Biesma DH, Banga JD. Postmethionine-load homocysteine determination for the diagnosis hyperhomocysteinaemia and efficacy of homocysteine lowering treatment regimens. Vase Med 2002; 7:29-33.
11. Guttuso T, McDermott MP, Su H, Kieburtz K. Effects of L-isoleucine and L-valine on hot flushes and serum homocysteine: a randomized controlled trial. Obstet Gynecol 2008; 112:109-115.
12. Bonaa KH, Njolstad I, Ueland PM, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006; 354:1578-1588.
13. Lonn E, Yusuf S, Arnold MJ, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006; 354:1567-1577.
14. Albert CM, Cook NR, Gaziano JM, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA 2008; 299:2027-2036.
15. Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004; 291:565-575.
16. U.S. Department of Health and Human Services FDA. Guidance for industry: estrogen and estrogen/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms-recommendations for clinical evaluation. Available at: http://www.fda.gov/cder/guidance/5412dft.pdf. Accessed July 6, 2008.
17. Bergmans MG, Merkus JM, Corbey RS, Schellekens LA, Ubachs JM. Effect of Bellergal Retard on climacteric complaints: a double-blind, placebo-controlled study. Maturitas 1987; 9:227-234.
18. Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebocontrolled study. Menopause 2000; 7:236-242. (Pubitemid 30445953)
19. Evans ML, Pritts E, Vittinghoff E, McClish K, Morgan KS, Jaffe RB. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial. Obstet Gynecol 2005; 105:161-166. (Pubitemid 40189927)
20. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28:193-213.
21. Barentsen R, van de Weijer PH, van Gend S, Foekema H. Climacteric symptoms in a representative Dutch population sample as measured with the Greene Climacteric Scale. Maturitas 2001; 38:123-128. (Pubitemid 32295925)
22. Little RJA, Rubin DB. Statistical Analysis with Missing Data, 2nd ed. Hoboken, NJ: John Wiley and Sons, 2002.
23. Hettmansperger T. Statistical Inference Based on Ranks. New York: John Wiley and Sons, 1984.
24. 2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 2002; 42:229-236.
25. ClinicalTrials.gov. Pregabalin in treating women with hot flashes. Available at: http://clinicaltrials.gov/ct2/show/NCT00702949?term= lyrica+hot+flash&rank=l . Accessed December 20. 2008.
26. Ohayon MM. Severe hot flashes are associated with chronic insomnia. Arch Intern Med 2006; 166:1262-1268.